References
- Kelly EA, Houtman JJ, Jarjour NN. Inflammatory changes associated with
circadian variation in pulmonary function in subjects with mild
asthma. Clin Exp Allergy . 2004; 34 :227-33. doi:
10.1111/j.1365-2222.2004.01866.x.
- Weidner J, Bartel S, Kılıç A, Zissler UM, Renz H, Schwarze J, et al.
Spotlight on microRNAs in allergy and asthma. Allergy . 2020.
doi: 10.1111/all.14646. Epub ahead of print.
- Agache I, Akdis CA. Precision medicine and phenotypes, endotypes,
genotypes, regiotypes, and theratypes of allergic diseases. J
Clin Invest . 2019; 129 :1493-1503. doi: 10.1172/JCI124611.
- Collison A, Mattes J, Plank M, Foster PS. Inhibition of house dust
mite-induced allergic airways disease by antagonism of microRNA-145 is
comparable to glucocorticoid treatment. J Allergy Clin Immunol.2011; 128 :160-167.e4. doi: 10.1016/j.jaci.2011.04.005.
- Siddiqui S, Johansson K, Joo A, Bonser LR, Koh KD, Le Tonqueze O, et
al. Epithelial miR-141 regulates IL-13-induced airway mucus
production. JCI Insight . 2021; 6 :e139019. doi:
10.1172/jci.insight.139019.
- Rodrigo-Muñoz JM, Cañas JA, Sastre B, Rego N, Greif G, Rial M, et al.
Asthma diagnosis using integrated analysis of eosinophil microRNAs.Allergy . 2019; 74 :507-517. doi: 10.1111/all.13570.